Balancing these tools with operational efficiencies can aid CROs in meeting the evolving needs of sponsors.
Guillaume Gigon
Advertisement
VP of Technology and AI, Innovaderm
Articles by Guillaume Gigon
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
2
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
3
Reducing Site Burden Through Better Technology Integration in Clinical Trials
4
ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
